Skip to main content
Clinical Trials/NL-OMON40170
NL-OMON40170
Completed
Not Applicable

Role of endothelial surface layer in regulating the sodium balance and extracellular fluid volume - SALT study

Academisch Medisch Centrum0 sites18 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
fysiologie van natrium- en volumebalans
Sponsor
Academisch Medisch Centrum
Enrollment
18
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • Healthy subjects
  • \- Male between 18 and 40 years of age
  • \- Healthy, as determined by a responsible and experienced physician, based on a medical evaluation including medical history, physical examination (PE) and laboratory tests carried out in the screening visit.
  • \- Non\-treated office blood pressure \* 140/90 mmHg
  • \- Capable of giving written informed consent and able to comply with the requirements and restrictions listed in the informed consent form

Exclusion Criteria

  • \- An office blood pressure \>140/90 mmHg
  • \- A body mass index \> 30 kg/m2
  • \- A major illness in the past 3 months or any significant chronic medical illness that the Investigator would deem unfavourable for enrolment, including chronic inflammatory diseases
  • \- A history of any type of malignancy within the past 5 years with the exception of successfully treated basal cell cancer of the skin
  • \- A history of any renal disease
  • \- A history of cardiovascular disease (in the past 6 months) defined as documented coronary artery disease including myocardial infarction, (un\-)stable angina pectoris or acute coronary syndrome, precutenaous transluminal coronary angioplasty, coronary artery bypass grafting, cerebrovascular disease including ischemic and hemorrhagic stroke or a subarachnodial bleeding, or peripheral artery disease including aortic aneurysmata
  • \- A history of coagulation disorders
  • \- A history of primary hyperlipoproteinemias
  • \- A history of hypersensitivity or allergy to iodium or to shell fish
  • \- A history, within 3 years, of drug abuse (including benzodiazepines, opioids, amphetamine, cocaine, THC, methamphetamine)

Outcomes

Primary Outcomes

Not specified

Similar Trials